GILD Stock Ownership Activity

GILEAD SCIENCES INC 13F holders

2 value investing gurus have made changes to the GILEAD SCIENCES INC (GILD) position according to the gurus' latest SEC quarterly report(s). GILD has been completely sold out by 1 guru(s), the number of GILD shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying GILD now?

According to the latest SEC filing(s) GILEAD SCIENCES INC (GILD) has not been purchased by any super investor.

To see more about who is investing in GILEAD SCIENCES INC (GILD), please go to the GILD ownership page.

2017 Q2 (4 results)
Ronald Muhlenkamp
-0.02%
-40
-0.00%
5.24%
Bill Miller
-2.01%
-4,136
-0.02%
0.65%
Paul Isaac
-97.60%
-209,838
-4.16%
0.00%
Eric H. Schoenstein
-100.00%
-5,058
-0.01%
0.00%
Current price: $89.76 26.81% AVG reported price*: $70.78
2017 Q1 (3 results)
Paul Isaac
+59.26%
+67,600
+1.52%
3.44%
Ronald Muhlenkamp
+5.98%
+7,065
+0.28%
2.76%
Bill Miller
-19.05%
-88,800
-0.31%
1.33%
Current price: $89.76 32.16% AVG reported price*: $67.92
2016 Q4 (4 results)
Paul Isaac
+321.88%
+103,000
+2.28%
2.99%
Ronald Muhlenkamp
-0.70%
-870
-0.04%
2.95%
Bill Miller
-0.96%
-4,500
-0.02%
1.78%
Eric H. Schoenstein
-7.68%
-425
-0.00%
0.01%
Current price: $89.76 25.38% AVG reported price*: $71.59
2016 Q3 (5 results)
Paul Isaac
+60.00%
+12,000
+0.33%
0.87%
Eric H. Schoenstein
+19.11%
+940
+0.00%
0.01%
Ronald Muhlenkamp
-1.15%
-2,091
-0.08%
5.42%
Bill Miller
-2.08%
-5,950
-0.05%
1.26%
John Armitage
-100.00%
-1,285,913
-1.32%
0.00%
Current price: $89.76 13.42% AVG reported price*: $79.14
2016 Q2 (5 results)
Paul Isaac
buy
+20,000
+0.58%
0.58%
Eric H. Schoenstein
+11.06%
+254
+0.00%
0.00%
Ronald Muhlenkamp
-0.45%
-569
-0.03%
4.10%
Bill Miller
-8.24%
-43,125
-0.23%
2.59%
John Armitage
-69.09%
-2,874,036
-2.93%
0.00%
Current price: $89.76 7.65% AVG reported price*: $83.38
2016 Q1 (4 results)
Eric H. Schoenstein
+17.51%
+660
+0.00%
0.01%
John Armitage
+5.36%
+230,218
+0.20%
3.96%
Ronald Muhlenkamp
+0.01%
+15
+0.00%
8.24%
Bill Miller
-9.33%
-53,900
-0.25%
2.39%
Current price: $89.76 2.29% AVG reported price*: $91.86
2015 Q4 (4 results)
Bill Miller
+7.14%
+23,662
+0.15%
1.38%
Ronald Muhlenkamp
-0.01%
-15
-0.00%
6.95%
Eric H. Schoenstein
-9.38%
-390
-0.00%
0.01%
John Armitage
-23.24%
-955,006
-1.36%
3.31%
Current price: $89.76 11.27% AVG reported price*: $101.16
2015 Q3 (3 results)
John Armitage
+39.79%
+1,591,342
+1.77%
6.20%
Ronald Muhlenkamp
-0.29%
-630
-0.02%
6.58%
Eric H. Schoenstein
-10.34%
-480
-0.00%
0.01%
Current price: $89.76 8.55% AVG reported price*: $98.15
2015 Q2 (3 results)
John Armitage
+406.01%
+3,209,057
+4.76%
5.93%
Ronald Muhlenkamp
-0.05%
-120
-0.00%
5.77%
Eric H. Schoenstein
-12.29%
-578
-0.00%
0.01%
Current price: $89.76 23.33% AVG reported price*: $117.07
2015 Q1 (4 results)
Eric H. Schoenstein
+0.57%
+30
+0.00%
0.01%
Ronald Muhlenkamp
-0.09%
-205
-0.00%
4.54%
Bill Miller
-21.72%
-118,912
-0.55%
1.59%
John Armitage
-31.67%
-366,367
-0.49%
1.06%
Current price: $89.76 8.52% AVG reported price*: $98.13
2014 Q4 (4 results)
Eric H. Schoenstein
buy
+5,260
+0.01%
0.01%
Ronald Muhlenkamp
+6.10%
+10,264
+0.24%
3.40%
Bill Miller
-0.23%
-1,216
-0.01%
1.93%
John Armitage
-79.70%
-3,929,310
-5.73%
1.26%
Current price: $89.76 4.78% AVG reported price*: $94.27
2014 Q3 (3 results)
Ronald Muhlenkamp
+42.59%
+40,679
+1.20%
2.65%
Bill Miller
+3.01%
+15,554
+0.09%
2.40%
John Armitage
-7.31%
-449,423
-0.64%
8.16%
Current price: $89.76 15.68% AVG reported price*: $106.45
2014 Q2 (4 results)
Bill Miller
buy
+670,075
+2.23%
2.23%
John Armitage
buy
+4,273,376
+8.07%
5.61%
Ronald Muhlenkamp
-24.63%
-46,117
-0.70%
2.08%
David Rolfe
-100.00%
-1,907,287
-2.36%
0.00%
Current price: $89.76 8.26% AVG reported price*: $82.91
50 of 111

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.